VX-710 inhibitor of the MDR-1 P-glycoprotein pump that removes cancer drugs from cells: Began Phase I trial to assess VX-710 in combination with doxorubicin, in

Vertex Pharmaceuticals Inc. (VRTX), Cambridge, Mass.
Product:

Read the full 73 word article

How to gain access

Continue reading with a
two-week free trial.